References
- Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480–487
- Weatherall DJ. Thalassemia as a global health problem: Recent progress toward its control in the developing countries. Ann N Y Acad Sci. 2010;1202:17–23
- Giardine B, Borg J, Viennas E, et al. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2014;42(Database issue):D1063–D1069 (http://globin.cse.psu.edu)
- Guida V, Colosimo A, Fiorito M, et al. Denaturing HPLC-based assay for molecular screening of nondeletional mutations causing α-thalassemias. Clin Chem. 2004;50(7):1242–1245
- O’Riordan S, Hien TT, Miles K, et al. Large scale screening for haemoglobin disorders in southern Vietnam: Implications for avoidance and management. Br J Haematol. 2010;150(3):359–364
- Nguyen HV, Sanchaisuriya K, Nguyen D, et al. Thalassemia and hemoglobinopathies in Thua Thien Hue Province, Central Vietnam. Hemoglobin. 2013;37(4):333–342
- Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia. Blood. 2000;95(1):360–362
- Nguyen VH, Sanchaisuriya K, Wongprachum K, et al. Hemoglobin Constant Spring is markedly high in women of an ethnic minority group in Vietnam: A community-based survey and hematologic features. Blood Cells Mol Dis. 2014;52(4):161–165
- Harteveld CL, Higgs DR. α-Thalassaemia. Orphanet J Rare Dis. 2010;5:13. doi: 10.1186/1750-1172-5-13